NJ
Navjeewan Jatinder Khosla
About Navjeewan Jatinder Khosla
Data last updated:
Navjeewan Jatinder Khosla is a Director at Medgenome Labs Limited (since 2024), Nominee Director at Surya Children's Medicare Private Limited (since 2026) and Nominee Director at Surya Mother And Child Care Private Limited (since 2026), and holds 3 more current directorships. The companies operate in Healthcare, Outsourcing and Agriculture. The 5 current companies with reported revenue have a combined latest revenue of ₹680 Cr; the largest is Medgenome Labs Limited at ₹407 Cr (FY 2025). Earlier, Navjeewan Jatinder Khosla was a Director at Agnext Technologies Private Limited (2024–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medgenome Labs Limited U73100KA2013PLC084414 | Director | 07 Nov 2024 | 2013 | ₹407 Cr (FY 2025) | Active |
 Surya Children's Medicare Private Limited U85100MH2010PTC203093 | Nominee Director | 14 Jan 2026 | 2010 | ₹200 Cr (FY 2023) | Active |
 Surya Mother And Child Care Private Limited U74999PN2013PTC158903 | Nominee Director | 14 Jan 2026 | 2013 | ₹65.32 Cr (FY 2025) | Active |
 Surya Ivf Clinic Private Limited U85191MH2016PTC272381 | Nominee Director | 14 Jan 2026 | 2016 | ₹4.87 Cr (FY 2025) | Active |
 Surya Mother And Child Care Jaipur Private Limited U85110MH2016PTC356292 | Nominee Director | 14 Jan 2026 | 2016 | ₹3.64 Cr (FY 2025) | Active |
 Novo Holdings Advisory India Private Limited U66190MH2025FTC451243 | Director | 26 Jun 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Agnext Technologies Private Limited U72900PB2016PTC045727 | Director | 24 Jun 2024 | 2016 | ₹202 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Navjeewan Jatinder Khosla
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navjeewan Jatinder Khosla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navjeewan Jatinder Khosla
Navjeewan Jatinder Khosla currently holds 6 directorships: Medgenome Labs Limited (Director, since 07 Nov 2024, revenue ₹407 Cr (FY 2025)); Surya Children's Medicare Private Limited (Nominee Director, since 14 Jan 2026, revenue ₹200 Cr (FY 2023)); Surya Mother And Child Care Private Limited (Nominee Director, since 14 Jan 2026, revenue ₹65.32 Cr (FY 2025)); Surya Ivf Clinic Private Limited (Nominee Director, since 14 Jan 2026, revenue ₹4.87 Cr (FY 2025)); Surya Mother And Child Care Jaipur Private Limited (Nominee Director, since 14 Jan 2026, revenue ₹3.64 Cr (FY 2025)); and 1 more.
Navjeewan Jatinder Khosla was first appointed on 24 Jun 2024 as Director at Agnext Technologies Private Limited. The most recent appointment on record is 14 Jan 2026 at Surya Mother And Child Care Jaipur Private Limited.
The 5 current companies of Navjeewan Jatinder Khosla that report revenue have a combined latest revenue of ₹680 Cr: Medgenome Labs Limited ₹407 Cr (FY 2025); Surya Children's Medicare Private Limited ₹200 Cr (FY 2023); Surya Mother And Child Care Private Limited ₹65.32 Cr (FY 2025); Surya Ivf Clinic Private Limited ₹4.87 Cr (FY 2025); Surya Mother And Child Care Jaipur Private Limited ₹3.64 Cr (FY 2025).
Navjeewan Jatinder Khosla held 1 earlier board appointment: Agnext Technologies Private Limited (Director, 24 Jun 2024 to 17 Jul 2025).
The current boards of Navjeewan Jatinder Khosla's companies include Mahesh Pratapneni (Medgenome Labs Limited), Prasad Bhagwan Shejale (Medgenome Labs Limited), Shankar Mahadevappa Prasad (Medgenome Labs Limited), Surajit Chakrabartty (Medgenome Labs Limited), Surajit Chakrabartty (Medgenome Labs Limited), Suryaprakasam Vedam Lakshmi Ramprasad (Medgenome Labs Limited), among others.